Cargando…
A Novel Sphingosine Kinase Inhibitor Suppresses Chikungunya Virus Infection
Chikungunya virus (CHIKV) is a re-emerging arbovirus in the alphavirus genus. Upon infection, it can cause severe joint pain that can last years in some patients, significantly affecting their quality of life. Currently, there are no vaccines or anti-viral therapies available against CHIKV. Its spre...
Autores principales: | Oyewole, Opeoluwa O., Dunnavant, Kyle, Bhattarai, Shaurav, Kharel, Yugesh, Lynch, Kevin R., Santos, Webster L., Reid, St. Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229564/ https://www.ncbi.nlm.nih.gov/pubmed/35746595 http://dx.doi.org/10.3390/v14061123 |
Ejemplares similares
-
Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail
Derivatives Deliver Potent and Selective Analogues
por: Pashikanti, Srinath, et al.
Publicado: (2022) -
Mechanism of sphingosine 1-phosphate clearance from blood
por: Kharel, Yugesh, et al.
Publicado: (2020) -
Drugging Sphingosine Kinases
por: Santos, Webster L., et al.
Publicado: (2014) -
Photoacoustic microscopy reveals the hemodynamic basis of sphingosine 1-phosphate-induced neuroprotection against ischemic stroke
por: Cao, Rui, et al.
Publicado: (2018) -
Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors
por: Kharel, Yugesh, et al.
Publicado: (2018)